Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies

• Norbert Stefan ,

  * E-mail: norbert.stefan@med.uni-tuebingen.de

  Affiliations Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany, Institute of Diabetes Research and Metabolic Diseases, Member of the German Center for Diabetes Research (DZD), Tübingen, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Qi Sun,

  Affiliations Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Andreas Fritsche,

  Affiliations Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany, Institute of Diabetes Research and Metabolic Diseases, Member of the German Center for Diabetes Research (DZD), Tübingen, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Jürgen Machann,

  Affiliations Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Fritz Schick,

  Affiliation Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Felicia Gerst,

  Affiliations Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany, Institute of Diabetes Research and Metabolic Diseases, Member of the German Center for Diabetes Research (DZD), Tübingen, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Charlotte Jeppesen,

  Affiliations Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Hans-Georg Joost,

  Affiliations Department of Pharmacology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Frank B. Hu,

  Affiliations Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Heiner Boeing,

  Affiliation Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany

  ⨯
• Susanne Ullrich,

  Affiliations Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany, Institute of Diabetes Research and Metabolic Diseases, Member of the German Center for Diabetes Research (DZD), Tübingen, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Hans-Ulrich Häring,

  Affiliations Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany, Institute of Diabetes Research and Metabolic Diseases, Member of the German Center for Diabetes Research (DZD), Tübingen, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯
• Matthias B. Schulze

  Affiliations Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, München, Germany

  ⨯